• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. TRUE DILATATION BALLOON VALVULOPLASTY CATHETER; VALVULOPLASTY BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. TRUE DILATATION BALLOON VALVULOPLASTY CATHETER; VALVULOPLASTY BALLOON Back to Search Results
Catalog Number 0224512
Device Problem Material Rupture (1546)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/20/2017
Event Type  malfunction  
Manufacturer Narrative
No medical records and no medical images were provided to the manufacturer.The lot number for the device was provided.The device history records are currently under review.The facility rep stated that the device was available for evaluation.A sample return kit was sent to the facility and is pending return.The results of the anticipated device evaluation will be provided upon completion of the event investigation.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that during a transcatheter aortic valve replacement the balloon allegedly would not inflate past 5 atm.The health care provider deflated and removed the balloon successfully from the patient.Upon further inspection of the balloon on the back table, the health care provider found a pinhole rupture near the proximal end of the balloon.Another balloon was used to complete the procedure.There was no reported patient injury.
 
Manufacturer Narrative
Manufacturing review: the device history records were reviewed with special attention to the raw materials, subassemblies, manufacturing process and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.This is the only complaint reported to date for this lot number and failure mode.Visual/microscopic inspection: as the sample was not returned for evaluation, a visual/microscopic inspection could not be performed.Functional/performance evaluation: as the sample was not returned for evaluation, a functional/performance evaluation could not be performed.Medical records review: medical records were not provided; therefore, a review could not be performed.Image/photo review: images/photos were not provided; therefore, a review could not be performed.Conclusion: the investigation is inconclusive, as the sample was not returned for evaluation.The definitive root cause for the reported rupture could not be determined based upon available information.It is unknown whether patient and/or procedural issues contributed to the event.Labeling review: the current ifu (instructions for use) states: indications: the true dilatation balloon valvuloplasty catheter is indicated for balloon aortic valvuloplasty.Warnings & precautions: do not exceed maximum inflation pressure indicated on label.Excess inflation pressure can cause balloon rupture and the inability to withdraw catheter through introducer sheath.Potential complications/adverse events: in the very unlikely event of balloon burst or rupture, balloon could be more difficult to remove through the sheath and could require introducer sheath removal.Potential complications include, but are not limited to: tissue perforation, conduction system injury, thromboembolic events, hematoma, cardiovascular injury, arrhythmia development, annular or valvular tearing or trauma, restenosis development, inflammation, infection.
 
Event Description
It was reported that during a transcatheter aortic valve replacement the balloon allegedly would not inflate past 5 atm.The health care provider deflated and removed the balloon successfully from the patient.Upon further inspection of the balloon on the back table, the health care provider found a pinhole rupture near the proximal end of the balloon.Another balloon was used to complete the procedure.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRUE DILATATION BALLOON VALVULOPLASTY CATHETER
Type of Device
VALVULOPLASTY BALLOON
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key6795203
MDR Text Key82813122
Report Number2020394-2017-00969
Device Sequence Number1
Product Code OZT
UDI-Device Identifier00801741091001
UDI-Public(01)00801741091001
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K150667
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/08/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/28/2020
Device Catalogue Number0224512
Device Lot NumberGFBS1098
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/20/2017
Initial Date FDA Received08/15/2017
Supplement Dates Manufacturer Received09/05/2017
Supplement Dates FDA Received09/08/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/09/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age80 YR
Patient Weight91
-
-